BioSpace News Archive

InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the fourth quarter and full year 2020 before the Nasdaq market opens on Wednesday, February 10, 2021.

Biond Biologics Ltd. (“Biond” or the “Company”), a privately-held biopharmaceutical company, developing novel immunotherapies for cancer and a platform enabling the intracellular delivery of biologics, today announced that it has entered into an exclusive worldwide license agreement with Sanofi (EURONEXT: SAN) (NASDAQ: SNY), for the development and commercialization of BND-22.

In support of a groundbreaking partnership with the Department of Health and Human Services to make the U.S. one of the safest nations in the world for women to give birth, March of Dimes, the leading organization fighting for the health of all moms and babies, announced it has received funding from UnitedHealthcare.

Clinicians at Variantyx, a leader in high complexity hereditary disease testing, recently completed analysis of their 2,500th patient genome

Trial Results Mark a Significant Milestone in the Development of a Trait that Provides Tolerance to White Mold (Sclerotinia) in Canola/Oil Seed Rape Plants

At a time when we’re constantly looking at screens, data confirms blue light blocking screen protectors improve sleep with data from over 850 nights

Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the completion of a $60 million supplemental Series D crossover financing with new investors, anchored by CR-CCT Industry Pilot Fund together with Redmile Group and Perceptive Advisors

Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing innovative treatments for myeloproliferative neoplasms, today announced that Hugh Young Rienhoff, Jr., M.D., CEO, will present at the 39th Annual J.P. Morgan Healthcare Conference at 4:55 p.m.

Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners (“Arsenal”), announced today the acquisition of Mosaic Laboratories LLC (“Mosaic”), a California-based company offering histology and immunohistochemistry services to global pharmaceutical clients

Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today that it has appointed pain management expert Dr. Daniel Richman to the Company’s Board of Advisors.